Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026
- REP-MA-3086
- 2017-03-02
- Category: Healthcare, Pharmaceuticals and Medical devices
- 176 Pages
- Format:
Attenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period
Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0.
Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines
Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments.
There are international guidelines on the usage of livestock identification and traceability systems (LITS) for better herd management, identifying zoonosis and managing animal health and incorporating food safety. However, most countries in the MEA region fail to implement proper LITS thereby affecting effective animal disease management. This is expected to fuel the demand for protective maintenance of animal health through early attenuated live vaccinations in order to avoid the spread of infectious diseases. The countries within the MEA region and Central Europe are increasingly dependent on live stock trading as a means of survival. Furthermore, in order to address chronic food insecurity in rural areas, animals are transferred from one place to another. This is fuelling demand for adequate vaccinations as an infection affecting one of the herds could easily spread to another and lead to mass losses. This factor is creating a positive impact on attenuated live vaccinations in the region.
Attenuated live vaccines are expected to witness increased demand throughout the forecast period in Jordan
The attenuated live vaccines segment is expected to witness a significant CAGR given greater adoption in commercial farms in the UAE veterinary vaccines market. Lower dosages and repetition are factors that are expected to contribute towards greater demand for attenuated live vaccines among all animal segments in Turkey. In Jordan, attenuated live vaccines are expected to witness increased demand throughout the forecast period. Lack of organised animal rearing and tracking practices hinder estimation of demand for attenuated live vaccines in Sudan.
Scenario of Local Manufacturing and Veterinary Vaccine Registration
“The MEA region accounts for a vast livestock population; however, it is largely dependent on imports for the supply of adequate veterinary vaccines. Only six countries have the facility to produce vaccines locally. These include Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey. Local produce acceptance is higher as regulatory authorities have relatively fewer requirements for local vaccines than imported ones. The time duration for imported vaccines to obtain the required registration is also longer. Only four countries follow the international norms of OIE although the OIE has not yet established official international standards in this respect.”
--- Analyst – Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights
Our expert team of analysts provide in-depth information about the various strategies adopted by the key players in the Middle East veterinary vaccines market in a new report published by Future Market Insights titled “Veterinary Vaccines Market: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026.” According to the analysts, a market player can clearly gain an advantage in terms of correct demand estimation, if it has the local presence in terms of an office set up and resources, especially to tap sudden outbreaks such as Avian Influenza. After studying the market in detail, we found that the bigger the product portfolio, the greater the ability to operate at an intra-regional level and maintaining a healthy distributor portfolio is the key to garner higher margins, product visibility and sales. We have analysed that intense competition among existing players leads comparable players to increase their available product portfolio. We have also considered the overall market approach and have come to a conclusion that veterinarians and private veterinary pharmacies are key stakeholders in the sales and distribution of essential veterinary vaccines.
We have done a comprehensive analysis of target geographies which provides a 360o forecast of various countries in the Middle East. According to our team of experts, Turkey, Egypt, UAE, and Jordan are the key markets in the MEA region. Apart from this, our extensive research focusses on distributors, who play the most important role in the route-to-market chain as the markets are largely dependent on imported vaccines. Players in the market are also concentrating on the formation of formal vaccination schedules and harmonisation of registration guidelines. A consistent marketing approach on bovine and poultry vaccines is expected which are generally administered annually or biannually.
Value chain analysis with insights on essential vaccines is the uniqueness of this report
Our exclusive report on the Middle East veterinary vaccines market starts with an overview of the parent market of veterinary vaccines. The presence of a large number of livestock animals, communal herding practices, and lack of domestic testing and vaccine manufacturing facilities are factors garnering interest in the Middle East veterinary vaccines market from industry heavyweights. We have covered the Middle East veterinary vaccines market performance in terms of revenue, followed by drivers and restraints from the supply and demand perspectives. This is followed by trends and opportunities in the Middle East veterinary vaccines market. While examining the value chain of the Middle East veterinary vaccines market, we have offered pertinent insights on the following key points:
-
Animal product supply chains are complex in nature in most Middle Eastern markets
-
Supply chains are directly dependent on product registration and authorisation norms of individual countries
-
Exceptional stakeholders such as pet shops and pet shelters could be present in case of distribution of animal vaccines
-
For fisheries, the aquaculture association of individual countries could play a pivotal role
The competitive landscape has been included in this report to provide a dashboard view of key companies operating in the Middle East veterinary vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the Middle East veterinary vaccines market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the Middle East veterinary vaccines market. Detailed profiles of veterinary vaccines manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies.
Middle East Veterinary Vaccines Market: Segmentation
|
By Country |
By Vaccine Type |
By Disease Indication |
By Animal Type |
By Distribution Channel |
|---|---|---|---|---|
|
|
|
|
|
Extensive primary and secondary research to quantify market numbers
The forecast presented for the Middle East veterinary vaccines market assesses the total revenue generated in the Middle East veterinary vaccines market. While developing the forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome based on an analysis of supply side and demand side factors. For quantifying the market numbers, we have conducted extensive interviews with subject matter experts in the Middle East veterinary vaccines market. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the Middle East veterinary vaccines market.
As previously mentioned, the MEA veterinary vaccines market is split into various segments and all these segments have been analysed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the Middle East veterinary vaccines market.
Another key feature of this report is the analysis of the Middle East veterinary vaccines market by vaccine type, animal type, end user, disease indication and country; and the corresponding market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity analysis is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the Middle East veterinary vaccines market.
Middle East Veterinary Vaccines Market Reports - Table of Contents
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview
3. Middle East Veterinary Vaccines Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain
4. Market Dynamics and USPs
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5.Standard Approval Process U.S.
4.6.Vaccines Labelling Requirements
4.7.Scenario of Local Manufacturing and Veterinary Vaccine Registration
4.8.Veterinary Medical Product Registration Timelines and Products
5. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Vaccine Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Vaccine Type
5.3. Y-o-Y Growth Projections By Vaccine Type
5.4. Market Value Forecast By Vaccine Type, 2016–2026
5.4.1. Live Attenuated Vaccines
5.4.2. Killed/Inactive Vaccines
5.4.3. Recombinant Vaccines
5.4.4. DNA Vaccines
5.4.5. Toxoid Vaccines
5.4.6. Others
5.5. Market Attractiveness By Vaccine Type
6. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Animal Type
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Animal Type
6.3. Y-o-Y Growth Projections By Animal Type
6.4. Market Value Forecast By Animal Type, 2016–2026
6.4.1. Companion Animal
6.4.1.1. Canine
6.4.1.2. Feline
6.4.1.3. Avian (Ornamental Bird)
6.4.2. Livestock Animal
6.4.2.1. Aquatic
6.4.2.2. Bovine
6.4.2.3. Porcine
6.4.2.4. Small Ruminant
6.4.2.5. Poultry
6.4.3. Equine
6.5. Market Attractiveness By Animal Type
7. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Disease Indication
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Disease Indication
7.3. Y-o-Y Growth Projections By Disease Indication
7.4. Market Value Forecast By Disease Indication, 2016–2026
7.4.1. Foot and Mouth Diseases
7.4.2. Avian Influenza
7.4.3. New Castle Disease
7.4.4. PPRS
7.4.5. Brucellosis
7.4.6. Canine Parvovirus
7.4.7. Others
7.5. Market Attractiveness By Disease Indication
8. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Distribution Channel
8.3. Y-o-Y Growth Projections By Distribution Channel
8.4. Market Value Forecast By Distribution Channel, 2016–2026
8.4.1. Hospital Pharmacies
8.4.2. Veterinary Clinics
8.4.3. Private Veterinary Pharmacies
8.4.4. Others ( Research Institutes, Laboratories)
8.5. Market Attractiveness By Distribution Channel
9. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Country
9.1. Basis Point Share (BPS) Analysis By Country
9.2. Y-o-Y Growth Projections By Country
9.3. Market Value Forecast By Country
9.3.1. UAE
9.3.2. KSA
9.3.3. Turkey
9.3.4. Jordan
9.3.5. Sudan
9.3.6. Egypt
9.3.7. Rest of MEA
9.4. Market Attractiveness By Country
10. UAE Veterinary Vaccines Market Analysis and Forecast
10.1.Market Value Forecast By Vaccine Type, 2016–2026
10.1.1. Live Attenuated Vaccines
10.1.2. Killed/Inactive Vaccines
10.1.3. Recombinant Vaccines
10.1.4. DNA Vaccines
10.1.5. Toxoid Vaccines
10.1.6. Others
10.2.Market Value Forecast By Disease Indication, 2016–2026
10.2.1. Foot and Mouth Diseases
10.2.2. Avian Influenza
10.2.3. New Castle Disease
10.2.4. PPRS
10.2.5. Brucellosis
10.2.6. Canine Parvovirus
10.2.7. Others
10.3.Market Value Forecast By Animal Type, 2016–2026
10.3.1. Companion Animal
10.3.1.1. Canine
10.3.1.2. Feline
10.3.1.3. Avian (Ornamental Bird)
10.3.2. Livestock Animal
10.3.2.1. Aquatic
10.3.2.2. Bovine
10.3.2.3. Porcine
10.3.2.4. Small Ruminant
10.3.2.5. Poultry
10.3.3. Equine
10.4.Market Value Forecast By Distribution Channel, 2016–2026
10.4.1. Hospital Pharmacies
10.4.2. Veterinary Clinics
10.4.3. Private Veterinary Pharmacies
10.4.4. Others ( Research Institutes, Laboratories)
11. KSA Veterinary Vaccines Market Analysis and Forecast
11.1.Market Value Forecast By Vaccine Type, 2016–2026
11.1.1. Live Attenuated Vaccines
11.1.2. Killed/Inactive Vaccines
11.1.3. Recombinant Vaccines
11.1.4. DNA Vaccines
11.1.5. Toxoid Vaccines
11.1.6. Others
11.2.Market Value Forecast By Disease Indication, 2016–2026
11.2.1. Foot and Mouth Diseases
11.2.2. Avian Influenza
11.2.3. New Castle Disease
11.2.4. PPRS
11.2.5. Brucellosis
11.2.6. Canine Parvovirus
11.2.7. Others
11.3.Market Value Forecast By Animal Type, 2016–2026
11.3.1. Companion Animal
11.3.1.1. Canine
11.3.1.2. Feline
11.3.1.3. Avian (Ornamental Bird)
11.3.2. Livestock Animal
11.3.2.1. Aquatic
11.3.2.2. Bovine
11.3.2.3. Porcine
11.3.2.4. Small Ruminant
11.3.2.5. Poultry
11.3.3. Equine
11.4.Market Value Forecast By Distribution Channel, 2016–2026
11.4.1. Hospital Pharmacies
11.4.2. Veterinary Clinics
11.4.3. Private Veterinary Pharmacies
11.4.4. Others ( Research Institutes, Laboratories)
12. Turkey Veterinary Vaccines Market Analysis and Forecast
12.1.Market Value Forecast By Vaccine Type, 2016–2026
12.1.1. Live Attenuated Vaccines
12.1.2. Killed/Inactive Vaccines
12.1.3. Recombinant Vaccines
12.1.4. DNA Vaccines
12.1.5. Toxoid Vaccines
12.1.6. Others
12.2.Market Value Forecast By Disease Indication, 2016–2026
12.2.1. Foot and Mouth Diseases
12.2.2. Avian Influenza
12.2.3. New Castle Disease
12.2.4. PPRS
12.2.5. Brucellosis
12.2.6. Canine Parvovirus
12.2.7. Others
12.3.Market Value Forecast By Animal Type, 2016–2026
12.3.1. Companion Animal
12.3.1.1. Canine
12.3.1.2. Feline
12.3.1.3. Avian (Ornamental Bird)
12.3.2. Livestock Animal
12.3.2.1. Aquatic
12.3.2.2. Bovine
12.3.2.3. Porcine
12.3.2.4. Small Ruminant
12.3.2.5. Poultry
12.3.3. Equine
12.4.Market Value Forecast By Distribution Channel, 2016–2026
12.4.1. Hospital Pharmacies
12.4.2. Veterinary Clinics
12.4.3. Private Veterinary Pharmacies
12.4.4. Others ( Research Institutes, Laboratories)
13. Jordan Veterinary Vaccines Market Analysis and Forecast
13.1.Market Value Forecast By Vaccine Type, 2016–2026
13.1.1. Live Attenuated Vaccines
13.1.2. Killed/Inactive Vaccines
13.1.3. Recombinant Vaccines
13.1.4. DNA Vaccines
13.1.5. Toxoid Vaccines
13.1.6. Others
13.2.Market Value Forecast By Disease Indication, 2016–2026
13.2.1. Foot and Mouth Diseases
13.2.2. Avian Influenza
13.2.3. New Castle Disease
13.2.4. PPRS
13.2.5. Brucellosis
13.2.6. Canine Parvovirus
13.2.7. Others
13.3.Market Value Forecast By Animal Type, 2016–2026
13.3.1. Companion Animal
13.3.1.1. Canine
13.3.1.2. Feline
13.3.1.3. Avian (Ornamental Bird)
13.3.2. Livestock Animal
13.3.2.1. Aquatic
13.3.2.2. Bovine
13.3.2.3. Porcine
13.3.2.4. Small Ruminant
13.3.2.5. Poultry
13.3.3. Equine
13.4.Market Value Forecast By Distribution Channel, 2016–2026
13.4.1. Hospital Pharmacies
13.4.2. Veterinary Clinics
13.4.3. Private Veterinary Pharmacies
13.4.4. Others ( Research Institutes, Laboratories)
14. Sudan Veterinary Vaccines Market Analysis and Forecast
14.1.Market Value Forecast By Vaccine Type, 2016–2026
14.1.1. Live Attenuated Vaccines
14.1.2. Killed/Inactive Vaccines
14.1.3. Recombinant Vaccines
14.1.4. DNA Vaccines
14.1.5. Toxoid Vaccines
14.1.6. Others
14.2.Market Value Forecast By Disease Indication, 2016–2026
14.2.1. Foot and Mouth Diseases
14.2.2. Avian Influenza
14.2.3. New Castle Disease
14.2.4. PPRS
14.2.5. Brucellosis
14.2.6. Canine Parvovirus
14.2.7. Others
14.3.Market Value Forecast By Animal Type, 2016–2026
14.3.1. Companion Animal
14.3.1.1. Canine
14.3.1.2. Feline
14.3.1.3. Avian (Ornamental Bird)
14.3.2. Livestock Animal
14.3.2.1. Aquatic
14.3.2.2. Bovine
14.3.2.3. Porcine
14.3.2.4. Small Ruminant
14.3.2.5. Poultry
14.3.3. Equine
14.4.Market Value Forecast By Distribution Channel, 2016–2026
14.4.1. Hospital Pharmacies
14.4.2. Veterinary Clinics
14.4.3. Private Veterinary Pharmacies
14.4.4. Others ( Research Institutes, Laboratories)
15. Egypt Veterinary Vaccines Market Analysis and Forecast
15.1.Market Value Forecast By Vaccine Type, 2016–2026
15.1.1. Live Attenuated Vaccines
15.1.2. Killed/Inactive Vaccines
15.1.3. Recombinant Vaccines
15.1.4. DNA Vaccines
15.1.5. Toxoid Vaccines
15.1.6. Others
15.2.Market Value Forecast By Disease Indication, 2016–2026
15.2.1. Foot and Mouth Diseases
15.2.2. Avian Influenza
15.2.3. New Castle Disease
15.2.4. PPRS
15.2.5. Brucellosis
15.2.6. Canine Parvovirus
15.2.7. Others
15.3.Market Value Forecast By Animal Type, 2016–2026
15.3.1. Companion Animal
15.3.1.1. Canine
15.3.1.2. Feline
15.3.1.3. Avian (Ornamental Bird)
15.3.2. Livestock Animal
15.3.2.1. Aquatic
15.3.2.2. Bovine
15.3.2.3. Porcine
15.3.2.4. Small Ruminant
15.3.2.5. Poultry
15.3.3. Equine
15.4.Market Value Forecast By Distribution Channel, 2016–2026
15.4.1. Hospital Pharmacies
15.4.2. Veterinary Clinics
15.4.3. Private Veterinary Pharmacies
15.4.4. Others ( Research Institutes, Laboratories)
16. Rest of MEA Veterinary Vaccines Market Analysis and Forecast
16.1.Market Value Forecast By Vaccine Type, 2016–2026
16.1.1. Live Attenuated Vaccines
16.1.2. Killed/Inactive Vaccines
16.1.3. Recombinant Vaccines
16.1.4. DNA Vaccines
16.1.5. Toxoid Vaccines
16.1.6. Others
16.2.Market Value Forecast By Disease Indication, 2016–2026
16.2.1. Foot and Mouth Diseases
16.2.2. Avian Influenza
16.2.3. New Castle Disease
16.2.4. PPRS
16.2.5. Brucellosis
16.2.6. Canine Parvovirus
16.2.7. Others
16.3.Market Value Forecast By Animal Type, 2016–2026
16.3.1. Companion Animal
16.3.1.1. Canine
16.3.1.2. Feline
16.3.1.3. Avian (Ornamental Bird)
16.3.2. Livestock Animal
16.3.2.1. Aquatic
16.3.2.2. Bovine
16.3.2.3. Porcine
16.3.2.4. Small Ruminant
16.3.2.5. Poultry
16.3.3. Equine
16.4.Market Value Forecast By Distribution Channel, 2016–2026
16.4.1. Hospital Pharmacies
16.4.2. Veterinary Clinics
16.4.3. Private Veterinary Pharmacies
16.4.4. Others ( Research Institutes, Laboratories)
17. Competition Landscape
17.1. Competition Dashboard
17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
17.2.1. JOVAC
17.2.2. Bioveta, Inc.
17.2.3. Intervac Pvt. Ltd.
17.2.4. Zoetis
17.2.5. Elanco
17.2.6. Merial
17.2.7. Merck & Co., Inc.
17.2.8. Bayer Pharma AG
17.2.9. Ceva
18. Assumptions and Acronyms Used
19. Research Methodology
Middle East Veterinary Vaccines Market Reports - List of Tables
Table 1: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 2: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 3: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 4: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 5: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 6: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 7: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 8: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 9: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 10: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 11: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 12: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 13: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 14: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 15: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 16: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 17: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 18: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 19: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 20: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 21: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 22: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 23: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 24: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 25: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 26: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 27: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 28: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 29: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 30: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 31: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 32: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 33: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Middle East Veterinary Vaccines Market Reports - List of Figures
Figure 01: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast 2016 and 2026
Figure 02: Middle East Veterinary Vaccines Market Value Share, By Vaccine Type, 2016
Figure 03: Middle East Veterinary Vaccines Market Value Share, By Animal Type, 2016
Figure 04: Middle East Veterinary Vaccines Market Value Share, By Disease Indication, 2016
Figure 05: Middle East Veterinary Vaccines Market Value Share, By End User, 2016
Figure 06: Middle East Veterinary Vaccines Market Value Share, By Country, 2016
Figure 07: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast, 2015–2026
Figure 08: Middle East Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026
Figure 09: Middle East Veterinary Vaccines Market Y-o-Y Growth, 2015–2026
Figure 10: Middle East Veterinary Vaccines Market Share Analysis (%) By Vaccine Type, 2016 & 2026
Figure 11: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Vaccine Type, 2015–2026
Figure 12: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines Segment, 2015 – 2026
Figure 13: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines Segment, 2015 – 2026
Figure 14: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccine Segment, 2015 – 2026
Figure 15: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccine Segment, 2015 – 2026
Figure 16: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) Recombinant Vaccines s Segment, 2015 – 2026
Figure 17: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 18: Middle East Veterinary Vaccines Market Attractiveness Analysis By Vaccine Type, 2016–2026
Figure 19: Middle East Veterinary Vaccines Market Share Analysis (%) By Animal Type, 2016 & 2026
Figure 20: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Animal Type, 2015–2026
Figure 21: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Companion Animals Segment, 2015 – 2026
Figure 22: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Livestock Animals Segment, 2015 – 2026
Figure 23: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Equine Segment, 2015 – 2026
Figure 24: Middle East Veterinary Vaccines Market Attractiveness Analysis By Animal Type, 2016–2026
Figure 25: Middle East Veterinary Vaccines Market Share Analysis (%) By Disease Indication, 2020 & 2026
Figure 26: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Disease Indication, 2015–2026
Figure 27: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Foot and Mouth Disease Segment, 2015 – 2026
Figure 28: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By New Castle Disease Segment, 2015 – 2026
Figure 29: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By PPRS Segment, 2015 – 2026
Figure 30: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Canine Parvovirus Segment, 2015 – 2026
Figure 31: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Brucellosis Segment, 2015 – 2026
Figure 32: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian Influenza Segment, 2015 – 2026
Figure 33: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 34: Middle East Veterinary Vaccines Market Attractiveness Analysis By Disease Indication, 2016–2026
Figure 35: Middle East Veterinary Vaccines Market Share Analysis (%) By End User, 2020 & 2026
Figure 36: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By End User, 2015–2026
Figure 37: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacies Segment, 2015 – 2026
Figure 38: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2015 – 2026
Figure 39: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Private Veterinary Pharmacies Segment, 2015 – 2026
Figure 40: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 41: Middle East Veterinary Vaccines Market Attractiveness Analysis By End User, 2016–2026
Figure 42: Middle East Veterinary Vaccines Market Share Analysis (%) By Country, 2016 & 2026
Figure 43: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Country, 2015–2026
Figure 44: UAE Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),
Figure 45: KSA Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),
Figure 46: Turkey Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 47: Jordan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 48: Sudan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 49: Egypt Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 50: Rest of MEA
Figure 51: Middle East Veterinary Vaccines Market Attractiveness Analysis By Country, 2016–2026